Neuraminidase as a novel therapeutic management strategy for Alzheimer’s disease: evidenced through molecular docking, molecular dynamic simulation and gene expression analysis
The study ends on a hopeful note for using oseltamivir to treat neurological diseases, but it suggests that future research should include a solid cell line study, an <i>in vitro</i> study, and a clinical study.
Authors
- Omar Awad Alsaidan (ORCID: https://orcid.org/0000-0002-2848-2932)
- Mohammad Jaffar Sadiq Mantargi (ORCID: https://orcid.org/0000-0002-3719-6241)
- Sami I. Alzarea (ORCID: https://orcid.org/0000-0003-4007-4023)
- Abdulaziz Ibrahim Alzarea (ORCID: https://orcid.org/0000-0003-0604-6299)
- Hassan H. Alhassan (ORCID: https://orcid.org/0000-0002-7174-9831)
- Tariq Ghazi Alsahli (ORCID: https://orcid.org/0000-0002-3001-867X)
- Muhammad Afzal (ORCID: https://orcid.org/0000-0003-2570-3223)
- Metab Alharbi (ORCID: https://orcid.org/0000-0001-8287-4470)
Institutions
- Jouf University (SA)
- King Saud University (SA)
- King Salman Center for Disability Research (SA)
- Batterjee Medical College
Publication Details
- Journal
- Frontiers in Chemistry
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fchem.2025.1574702
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.50
Funders
- King Salman Center for Disability Research